ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2020

Abstract Number: 0783

Role of Glutamine Metabolism in Rheumatoid Arthritis Fibroblast-Like Synoviocyte Aggressive Phenotype

Alyssa Torres1, Brian Pedersen1, Gary Firestein2, Elsa Sanchez-Lopez1 and Monica Guma3, 1University of California San Diego, La Jolla, 2University of California, San Diego, La Jolla, CA, 3Division of Rheumatology, University of California San Diego, Department of Medicine, Autonomous University of Barcelona, La Jolla, CA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2020

Keywords: Fibroblasts, Synovial, rheumatoid arthritis

Session Information

Date: Saturday, November 7, 2020

Title: RA – Etiology & Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibroblast-like synoviocyte (FLS) activation is a key component of rheumatoid arthritis (RA) inflamed synovium.  Their aggressive phenotype in RA contributes to initiation and perpetuation of destructive joint inflammation. Understanding changes in RA FLS metabolism is becoming a new focus of research in RA. We previously showed that the glutaminase gene, which encodes for the enzyme that generates glutamate from glutamine, is highly epigenetically regulated in RA FLS compared to osteoarthritis (OA) FLS. Here, we determined the importance of glutamine (gln) as an alternate carbon source to glucose for FLS and whether or not interference of this pathway can decrease the aggressive phenotype of FLS in RA.

Methods: Uptake of glutamine was determined by Glutamine/Glutamate-Glo kit by Promega. Dependence of glutamine by RA FLS was determined by functional assays, including invasion (matrigel assay), proliferation assays (EdU assay), and a migration assay (scratch assay), that were conducted using DMEM without glucose supplemented with dialyzed fetal bovine serum. We then used increasing amounts of glutamine before and after PDGF stimulation in the presence or absence of glucose. RA FLS were also incubated with CB-839 (300nM), a glutaminase inhibitor.

Results: Glutamine/glutamate luminescence test displayed significant glutamine uptake in FLS starved of glucose after PDGF stimulation (3938±10425 vs 1165±371.8, p< 0.0001). Functional assays revealed that 6mM glutamine (FLS cultured in a media without glucose) is sufficient as an alternate source of energy to 6mM glucose (FLS cultured in media without gln) in proliferation (6mM gln 0.3±0.07 vs 6mM glucose 0.37±0.21; ns) and invasion (6mM gln 21.47±1.34 vs 6mM glucose 20.91±1.3; ns). In addition, the use of glutamine allows for an increase of invasion (0mM gln 12.87±3.316 vs 6mM 18.83±3.236; p< 0.002), proliferation (0mM gln 8.752±4.7 vs. 6mM gln 40.55±14.07; p< 0.02), and migration (0mM gln 219.8±49.88 vs 6mM gln 186.4±45.90; p=0.0002) in the absence of glucose. Of interest, OA FLS do not migrate more on 6mM glutamine compared to 0mM glutamine (0mM gln 216.1±46.35 vs 6mM gln 219.4±58.64; ns). Experiments with CB-839 showed significant decrease in invasion (vehicle 23.11±3.161 vs CB-839 14.46±2.036 p< 0.0001) and proliferation (vehicle 0.2548±0.03589 vs CB-839 0.1278±0.02861 p< 0.0001) of RA FLS under glucose depletion with varying amounts of glutamine compared with vehicle control.

Conclusion: RA FLS are able to utilize glutamine as an alternative carbon source in the absence of glucose, which mimics the starvation conditions within the joint. Glutaminase could potentially be a good target to reduce the aggressive phenotype of FLS in RA.


Disclosure: A. Torres, None; B. Pedersen, None; G. Firestein, Eli Lilly, 2; E. Sanchez-Lopez, None; M. Guma, None.

To cite this abstract in AMA style:

Torres A, Pedersen B, Firestein G, Sanchez-Lopez E, Guma M. Role of Glutamine Metabolism in Rheumatoid Arthritis Fibroblast-Like Synoviocyte Aggressive Phenotype [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/role-of-glutamine-metabolism-in-rheumatoid-arthritis-fibroblast-like-synoviocyte-aggressive-phenotype/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-glutamine-metabolism-in-rheumatoid-arthritis-fibroblast-like-synoviocyte-aggressive-phenotype/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology